The visit and care checks
What happens in a remote visit?
Begin with what has changed. What feels hard now, and what would you like to do comfortably again?
Telehealth lets you discuss care on a video call, by phone or in an online exchange.
Choose how to start
Consider licensed telehealth care or an in-person clinic to check your symptoms. A clinician is the doctor or other health professional giving you care. Ask who you will see, whether they treat muscle problems and how an examination would be arranged.
Bring a short account
Note when the problem began, what activity came before it and how it affects your day. Have your medicine and supplement names nearby. Ask what the visit format will be before signing up.
Ask what needs an exam
An in-person exam or tests may be needed to assess your problem. The medical boards’ remote-care advice says the clinician must arrange them.
Ask whether the remote visit can assess your concern and what would lead to an in-person examination.
Leave with a next step
Ask what the assessment found, what remains unclear and who handles the next step. Get a way to ask the clinician questions after the visit.
Follow-up means checking back on how the care plan is going.
Expect more than a menu
Picking a treatment from a menu without anyone checking your health is not proper care. The Federation of State Medical Boards, the national group of boards that oversee doctors, said this in May 2026.
The group’s advice on treatment also says you must have a way to bring your own follow-up questions to the clinician.
These recommendations guide state medical boards; they do not create a law by themselves. As of September 26, 2026, care rules are set separately by each state.
Ask and note
How to check who is treating you
Check the license for your state
As of September 26, 2026, your clinician must hold a license or other permission from the state where you are located during your visit.
Tell the service which state you expect to be in for your appointment. Request the clinician’s license details and full name.
The source is licensing guidance from the U.S. Department of Health and Human Services.
A prescription is a clinician’s order for a medicine; a prescriber is the person who issues it.
Use the board’s record
State medical boards oversee doctors and keep records anyone can read about their licenses and penalties for breaking rules.
The federation’s state medical-board directory takes you to the boards responsible for these records.
Match the doctor’s name and check whether the license is current. Read any penalties and any claims by the board that the doctor broke its rules. If your clinician is not a doctor, find out which state board licenses them, then check its records.
A record without listed penalties does not measure the quality of care you will receive.
Check the pharmacy separately
If medicine is proposed, ask which pharmacy will make or send it. Ask for that name before sending payment.
The Food and Drug Administration (FDA) provides a state pharmacy license search.
FDA’s advice is to avoid an online pharmacy unless your state lists it as licensed.
FDA, a U.S. agency, is responsible for reviewing medicines.
Treatment checks
What peptide claims actually mean
Know what the word covers
The name “peptide” alone does not tell you what evidence supports a product.
Ask for the exact medicine name, its proposed use and the evidence for that use. Ask how any claimed recovery benefit was measured and what remains unknown.
Made to order has different limits
The word “compounding” describes a pharmacist or doctor making medicine to meet one patient’s particular needs.
Compounded medicines, as of September 26, 2026, are not FDA-approved.
Before compounded medicines are sold, FDA does not check their safety, their quality or whether they work.
FDA’s compounding explanation says a compounded medicine may fill a patient need that an approved medicine cannot address.
If a compounded product is proposed, ask why it is needed for you and what allows that ingredient to be used.
Check the peptide by name
As of September 26, 2026, no medicine with BPC-157 has FDA approval.
FDA reports too little human safety information to judge harm from BPC-157 for the proposed ways of giving it.
Read that concern in FDA’s peptide safety record.
TB-500 is another peptide.
As of September 26, 2026, BPC-157 and TB-500 cannot be raw ingredients in medicine a pharmacy makes for one person’s prescription.
The underlying FDA reviews cover BPC-157 and TB-500.
Ask the clinician to explain the evidence, what is unknown and what other care could address your concern.
If your sport tests athletes
As of September 26, 2026, the World Anti-Doping Agency’s sport rules ban BPC-157 and TB-500 both during competitions and between them.
Ask the person responsible for your sport’s banned-medicine rules to check any proposed medicine before treatment. Give them its exact name.
Read the agency’s sport rules.
Budget notes
How to get a useful price
Get a quote for the proposed care before paying or joining a plan.
Put the full price in writing
Request a written total for the assessment, any tests, medicine if prescribed, delivery and follow-up. Ask what is included and what is billed separately.
Compare quotes that cover the same work and time span.
Check what repeats
Ask whether payment is per visit or a membership. If a lower first bill is offered, ask for the later price and how long you must keep paying.
Ask how to cancel, what happens if no medicine is prescribed and which payments can be refunded. Get the answers before paying.
Check how much your insurance will pay
Ask your insurance company about the named visit and proposed treatment. Request the amount left for you to pay, including tests and follow-up.
Ask whether prior authorization is needed for any proposed medicine.
Name the exact visit and treatment when asking what insurance will pay.
Red-flag notes
When to pause before paying
A prescription is skipped
As of September 26, 2026, federal law permits supplying prescription medicine only after a valid prescription has been issued.
That requirement appears in the federal prescription rule.
A product is labelled for research
The words “For research use only” present a product as intended for research rather than treatment.
FDA sent warning letters in 2026 about products labelled “for research use only” but offered for people to use. It called those products drugs it had not approved.
These letters are FDA’s accusations against particular businesses, not court decisions.
Read FDA’s reasoning in a research-product warning letter.
A seller points to an FDA listing
“FDA registered” means a business is on file with FDA.
A drug-directory entry means a product appears on a government list of drugs.
As of September 26, 2026, neither an FDA registration nor a drug-directory entry means FDA has approved the product.
FDA explains the distinction in its approval guide.
Ask for the named product, the named clinician and the pharmacy filling the prescription. Check the records before sending payment.
Help after the visit is unclear
Ask who can answer medicine questions, how you can contact that person and what the plan is if you need an in-person exam.
Question notes
Take these questions into the visit
What are we trying to explain?
Describe the change in your muscle recovery and which daily tasks or activities it affects. Ask what the clinician needs to know before making a plan.
What would count as progress?
Ask how you and the clinician will judge whether the plan is helping. Agree on a date to check your progress and ask what happens next if you have not improved.
What else could I consider?
Ask about options that do not involve a medicine, as well as any proposed prescription. Ask what shows each option might help and what its drawbacks are.
Who handles the next step?
Ask who arranges an exam or tests, who reviews results and how the plan reaches your usual care team. Keep a copy of the answers.
Caution notes
When help cannot wait
MedlinePlus says a severe allergic reaction needs emergency medical care.
For severe symptoms such as breathing trouble or tongue swelling, it advises calling 911 or going immediately to the nearest emergency room.